Malalis, Sean Rogeth C.
HRN: 19-40-88 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/17/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/17/2022
12/24/2022
IV
450mg
Q8
PCAP C
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes